Palisade bio reports second quarter financial results and provides business update

Carlsbad, calif., aug. 24, 2021 (globe newswire) -- palisade bio, inc. (nasdaq: pali) (“palisade” or the “company”), a late-stage biopharma company advancing therapies for acute and chronic gastrointestinal (gi) complications, today provides a business update and releases its financial results for the second quarter ending june 30, 2021.

PALI Ratings Summary

PALI Quant Ranking